Exelixis
EXEL
#1488
Rank
S$18.50 B
Marketcap
S$74.67
Share price
0.78%
Change (1 day)
40.15%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): S$1.33 Billion

According to Exelixis's latest financial reports the company's current earnings are S$2.43 Billion. In 2025 the company made an earning of S$1.20 Billion, an increase over its 2024 earnings that were of S$0.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$1.33 B10.81%
2025 S$1.20 B38.08%
2024 S$0.87 B164.69%
2023 S$0.32 B9.89%
2022 S$0.29 B-20.33%
2021 S$0.37 B124.82%
2020 S$0.16 B-67.14%
2019 S$0.50 B-11.94%
2018 S$0.57 B185.09%
2017 S$0.20 B-325.82%
2016 -S$89.81 Million-58.12%
2015 -S$0.22 Billion-37.61%
2014 -S$0.35 Billion9.75%
2013 -S$0.32 Billion65.96%
2012 -S$0.19 Billion-291.63%
2011 S$98.46 M-195.59%
2010 -S$0.11 Billion-42.17%
2009 -S$0.18 Billion-18.98%
2008 -S$0.22 Billion-6.99%
2007 -S$0.24 Billion46.3%
2006 -S$0.17 Billion33.25%
2005 -S$0.13 Billion-30.92%
2004 -S$0.18 Billion44.29%
2003 -S$0.13 Billion12.86%
2002 -S$0.11 Billion22.79%
2001 -S$87.79 Million60.14%
2000 -S$54.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.51 B 2,431.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.83 B 567.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.15 B 893.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.15 B 591.50%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$9.83 B 642.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.23 B 1,050.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$10.08 B 661.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-S$10.81 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-S$37.14 Million-102.80%๐Ÿ‡บ๐Ÿ‡ธ USA